Diversity of the juxtamembrane and TKD1 mutations (Exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological data-Reference-Cited by-同舟云学术

Diversity of the juxtamembrane and TKD1 mutations (Exons 13-15) in the FLT3 gene with regards to mutant load, sequence, length, localization, and correlation with biological data

Published:2012-06-04 Issue:10 Volume:51 Page:910-924
ISSN:1045-2257
Container-title:Genes, Chromosomes and Cancer
language:en
Short-container-title:Genes Chromosom. Cancer

Author:

Schnittger Susanne,Bacher Ulrike,Haferlach Claudia,Alpermann Tamara,Kern Wolfgang,Haferlach Torsten

Publisher

Wiley

Subject

Cancer Research,Genetics

Reference20 articles.

1. Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group;Bennett;Ann Intern Med,1985

2. Identification of a novel type of ITD mutations located in nonjuxtamembrane domains of the FLT3 tyrosine kinase receptor;Breitenbuecher;Blood,2009

4. Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia;Cheson;J Clin Oncol,2003

5. The impact of FLT3 internal tandem duplication mutant level, number, size, and interaction with NPM1 mutations in a large cohort of young adult patients with acute myeloid leukemia;Gale;Blood,2008

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Clonal Dynamics and Relapse Risk Revealed by High-Sensitivity FLT3-Internal Tandem Duplication Detection in Acute Myeloid Leukemia;Modern Pathology;2024-09

2. The multi-kinase inhibitor CG-806 exerts anti-cancer activity against acute myeloid leukemia by co-targeting FLT3, BTK, and aurora kinases;Leukemia & Lymphoma;2024-06-13

3. A practical algorithm for acute myeloid leukaemia diagnosis following the updated 2022 classifications;Critical Reviews in Oncology/Hematology;2024-06

4. Emerging DNA Methylome Targets in FLT3-ITD-Positive Acute Myeloid Leukemia: Combination Therapy with Clinically Approved FLT3 Inhibitors;Current Treatment Options in Oncology;2024-05-02

5. FLT3‐ITD regulation of the endoplasmic reticulum functions in acute myeloid leukemia;Hematological Oncology;2024-05